COVID-19 Related Work Discounts
Available for anyone researching or working on COVID-19 related projects
To help assist the clinical research community in this battle, we are offering significantly discounted 18-month software licenses for anyone researching or working on projects related to COVID-19.
These licenses will be available for any Golden Helix product or software bundle until June 15th, 2020. It is our goal to make our solutions as affordable as possible for those actively working in this space and ensure your organization has a dependable, robust analysis solution to carry you through the end of 2021 with no additional or unpredicted costs.
If you are researching or working on projects related to COVID-19, please contact our team before June 15th through the form below or email to determine which of our software solutions best fit your needs.
Remote License Assistance Program
Available for all Golden Helix customers
We realize a significant portion of our customers are undergoing extreme disruptions in their workplace. With the recent quarantines, university closures, and organizations choosing to work remotely, we understand users may not have access to their devices with Golden Helix software installed. We have introduced a COVID-19 Remote Access Assistance Program to provide anyone experiencing these hardships additional, temporary license installations for remote work. We will continue to prioritize your health and well-being and will be a safe, supportive resource for you to continue conducting your analysis during this difficult time.
If you are in need of an additional license, please fill out the form below or email us at info@goldenhelix.com.
Recent Webcast
Next-Gen Sequencing of the SARS-CoV-2 Virus with Golden Helix
Watch on demand
Please enjoy this webcast recording. Should you have any questions about the content covered, please reach out to our team here.
New eBook:
Genetic Testing for the COVID-19 Virus and Other Pathogens
Written by Golden Helix President & CEO, Dr. Andreas Scherer
Download a complementary copy
In this eBook, Dr. Scherer summarizes to the best of his knowledge our current understanding of COVID-19 and the virus SARS-Cov-2 causing it. Most of the papers used to prepare this eBook were published since the beginning of this year. The body of knowledge is quickly expanding and evolving. Next-Generation Sequencing (NGS) can deliver significant insights in this process. This eBook outlines how NGS can be used and how Golden Helix software solutions can be utilized in the process.
Published Articles
Featured in the Clinical Lab Manager
Leveraging Next-Generation Sequencing Technology in the Fight Against COVID-19
Written by Golden Helix President & CEO, Dr. Andreas Scherer
With the help of NGS, we can enhance our understanding of the virus and its underlying pathways impacting humans. Read the full article on the Clinical Lab Manager blog here.
Request COVID-19 Assistance
If you are in need of any of the above resources, please fill out the form below or email us at info@goldenhelix.com.